B. Kevin Turner served as President and Chief Executive Officer of Legacy Core Scientific from July 2018 until his resignation in May 2021. Under an employment agreement executed in June 2018, he was engaged for an initial four-year term with provisions for automatic one-year renewals. He received an annual base salary of $300,000 and held membership on Legacy Core's board of directors.
Turner received multiple restricted stock unit (RSU) grants between September 2018 and August 2020, totaling approximately 9.0 million units. Upon separation in May 2021, 9,037,500 RSUs satisfied time-based vesting but remained subject to transaction-based vesting conditions with a three-year satisfaction window. He received total separation payments of $153,679, comprising $17,217 in COBRA payments and $136,462 in severance. Turner held shareholder interests in UnionJack LLC, Blockcap Inc., and the BCV Entities, entities that engaged in commercial hosting relationships with Legacy Core during his tenure and afterward.
Biography extracted from Core Scientific DEF 14A filed 2022-04-08 View cached copy (2026-09-27)Live source ↗
Compensation
| Year | Role as filed | Salary | Stock awards | Other | Total | Source |
|---|---|---|---|---|---|---|
| 2021 | Former President and Chief Executive Officer | $122.0K | — | $153.7K | $275.7K | View cached copy (2026-09-27)Live source ↗ |
| 2020 | Former President and Chief Executive Officer | $300.0K | $9.72M | $33.2K | $10.05M | View cached copy (2026-09-27)Live source ↗ |
As reported in the company's DEF 14A Summary Compensation Table (SEC Reg S-K Item 402(c)). Stock and option awards are grant-date fair values — what the award was worth on the day it was granted, not cash received and not what it is worth now. Every row here reconciles: its columns add up to the total the filing printed.